Dawnzera 80 mg
As listed in the register: Dawnzera 80 mg, Injektionslösung
80 mg ·
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Donidalorsenum
- Used in
- Blood, clotting and anaemia
- Made by
- Otsuka Pharmaceutical (Switzerland) GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Dawnzera wird angewendet zur routinemässigen Vorbeugung wiederkehrender Attacken des hereditären Angioödems (HAE) bei Erwachsenen und Jugendlichen ab 12 Jahren
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Otsuka Pharmaceutical (Switzerland) GmbH |
|---|---|
| Active substance | Donidalorsenum |
| Used in | Blood, clotting and anaemia |
| Strength | 80 mg |
| Classification | B06AC09 · Blood, clotting and anaemia |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Dawnzera 80 mg, Injektionslösung |
| Packs | 1 Fertigpen |
| Zulassungsnummer | 69883 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.